Effect of midazolam ,ondansetron and their combination on post strabismus surgery nausea-vomiting

Phase 3

Recruiting

• Conditions: H50.9; Strabistmus.; Unspecified strabismus

• Registration Number: IRCT20180416039326N8
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

ASA I-II
Candidate for strabismus surgery
Age between 18-62 years
The desire to participate in the study

Exclusion Criteria

Patient with motion sickness disease
Receiving an anti-emetic drug in the last 24 hours
Patient being treated with opioid
Pregnant women
smokers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity and frequency of nausea and vomiting. Timepoint: 0-2 and 2-24 hours after surgery. Method of measurement: Calculating nausea-vomiting frequency by questionnaire and nausea-vomiting intensity by Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Pain frequency. Timepoint: 1)First 0-2 hours 2) first 2-24 hours. Method of measurement: questionnaire.;Pain intensity. Timepoint: 1)first 0-2 hours 2)first 2-24 hours. Method of measurement: Visual analogue scale.;Time of extubation. Timepoint: After the end of the surgery. Method of measurement: A Period between end of the surgery and extubation measured By anesthesiologist.;Recovery time. Timepoint: After the end of the surgery. Method of measurement: A period between the end of the surgery and going to the ward that is measured by modified aldrete score.;Patient satisfaction. Timepoint: At the time of the patient discharge. Method of measurement: Likert scale.;Time of eating and drinking. Timepoint: After the end of the surgery. Method of measurement: The first time of eating and drinking After the surgery.